diphenyleneiodonium has been researched along with ellagic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devaraj, S; Jialal, I; Venugopal, SK; Yang, T | 1 |
| Chou, MM; Hsu, SL; Hsu, WC; Lee, WJ; Ou, HC; Sheu, WH; Tsai, KL; Tseng, JJ | 1 |
2 other study(ies) available for diphenyleneiodonium and ellagic acid
| Article | Year |
|---|---|
Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha.
Topics: Acetophenones; alpha-Tocopherol; Antioxidants; Biphenyl Compounds; Cell Line; Ellagic Acid; Enzyme Activation; Enzyme Inhibitors; Humans; Hyperglycemia; Isoenzymes; Mesylates; Monocytes; NADPH Oxidases; Oligodeoxyribonucleotides, Antisense; Onium Compounds; Phosphoproteins; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Superoxides | 2002 |
Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Cell Adhesion Molecules; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Ellagic Acid; Endothelial Cells; Enzyme Inhibitors; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Interleukin-8; Lipoproteins, LDL; NADPH Oxidases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Onium Compounds; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Scavenger Receptors, Class E; Signal Transduction; Superoxides | 2010 |